- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7525
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer ; volume:18 ; number:1 ; day:3 ; month:11 ; year:2020 ; pages:1-10 ; date:12.2020
Health and quality of life outcomes ; 18, Heft 1 (3.11.2020), 1-10, 12.2020
- Creator
-
Hagiwara, Yasuhiro
Shiroiwa, Takeru
Taira, Naruto
Kawahara, Takuya
Konomura, Keiko
Noto, Shinichi
Fukuda, Takashi
Shimozuma, Kojiro
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12955-020-01611-w
- URN
-
urn:nbn:de:101:1-2020121619020319880846
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hagiwara, Yasuhiro
- Shiroiwa, Takeru
- Taira, Naruto
- Kawahara, Takuya
- Konomura, Keiko
- Noto, Shinichi
- Fukuda, Takashi
- Shimozuma, Kojiro
- SpringerLink (Online service)
Other Objects (12)
Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer
Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after
Correction: Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after
Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13
Assessing measurement invariance in the EORTC QLQ-C30
Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients
Psychometric properties of the EORTC QLQ-C30 in Uganda
Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma
Normative data for the EORTC QLQ-C30 from the Austrian general population
Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials
Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients
Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer
Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after
Correction: Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after
Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13
Assessing measurement invariance in the EORTC QLQ-C30
Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients
Psychometric properties of the EORTC QLQ-C30 in Uganda
Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma
Normative data for the EORTC QLQ-C30 from the Austrian general population
Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials
Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients
Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer
Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer
Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after
Correction: Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after
Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13
Assessing measurement invariance in the EORTC QLQ-C30
Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients
Psychometric properties of the EORTC QLQ-C30 in Uganda
Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma
Normative data for the EORTC QLQ-C30 from the Austrian general population
Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials
Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients